Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
solifenacin (vesicare) (1 trial)
Urinary Bladder, Overactive (Phase 4)
Trials (1 total)
Trial APIs (1 total)